Adoptive Cell Therapy in Solid Tumors: The Who, How, and When?
While ACTs have yet to score any major wins in solid tumors beyond the early success of TILs, many early-stage clinical programs are slated to readout within the next few years.
This webinar will cover topic such as:
- What is Adoptive Cell Therapy
- Barriers To Success in Solid Tumors
- Role For Non-Curative Cell Therapy
- Role For Allogeneic
- Strategic Position for ACT
- What Exciting on the Horizon
